Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacist-guided darbepoetin dosing in haemodialysis patients
NL-OMON33197Recruiting
- Sponsor
- Franciscus Gasthuis & Vlietland
- Start
- Jun 2010
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of darbepoetin alfa and Iron in anemia of renal disease (2 arms), sponsored by Franciscus Gasthuis & Vlietland. Primary endpoint: Patients within haemoglobin target range. Started Jun 2010; status: recruiting.
02
Drugs
darbepoetin alfaIron
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on NL-OMON33197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33197.